Marijuana Rescheduling Just Reached Its Final Stage: What Schedule III Means for Hemp Buyers

Marijuana rescheduling is the most misreported story in cannabis, and the confusion is understandable: something real did happen in April, it was narrower than the headlines suggested, and a second, broader process has been running ever since. On August 17, 2026 that second process hit its last procedural milestone. Here is the accurate picture.

What actually happened in April

On April 28, 2026 the DEA and Acting Attorney General issued three simultaneous Federal Register actions. The one that mattered was a final rule moving two narrow categories from Schedule I to Schedule III, effective immediately and without notice-and-comment:

1. Marijuana in FDA-approved drug products
2. Marijuana subject to a state medical marijuana license

The expedited procedure was justified on Single Convention treaty grounds. At the same time, DEA issued a notice of hearing on the broader question of rescheduling all marijuana, and withdrew the prior hearing process.

The limitation people keep missing: bulk marijuana, unlicensed crops, and unapproved derivatives and extracts remain Schedule I. This was not general rescheduling. It was a carve-out for two defined categories.

What happened between June and August

The broader rescheduling hearing ran June 29 through July 15, 2026: eleven hearing days at DEA headquarters in Arlington, Virginia, before Chief Administrative Law Judge Derek C. Julius. Seven interested parties participated.

August 17, 2026 was the deadline for final post-hearing briefs, and they were filed.

DEA's own brief argued for rescheduling. The agency's position is that marijuana "no longer fits the statutory requirements for Schedule I because it has a currently accepted medical use," citing more than 30,000 practitioners treating over 6 million patients across 43 jurisdictions, and arguing its abuse profile fits Schedule III.

The opposition is organized and includes states. Smart Approaches to Marijuana filed jointly with Idaho, Indiana and Nebraska. The Tennessee Bureau of Investigation filed separately, challenging the Attorney General's authority. The National Drug and Alcohol Screening Association filed on federal workplace testing grounds, and two individual filers, a physician and a pharmacist, filed as well.

What happens next, and when

The procedure from here is defined but not calendared:

1. ALJ Julius issues a recommended decision. No deadline.
2. Parties have 20 days to file exceptions under 21 C.F.R. § 1316.66.
3. The DEA Administrator makes the final decision: and is not bound by the ALJ's recommendation.
4. The final order is reviewable in federal court under 21 U.S.C. § 877.

Anyone giving you a date for the outcome is guessing. There isn't one.

Why a hemp buyer should care

Schedule III would not legalize marijuana commercially. It would not create interstate cannabis commerce, it would not let dispensaries ship, and it would not make anything currently illegal legal to buy online. What it would do is change the economics on the other side of the aisle, in three ways that matter.

1. It removes 280E for state-licensed operators. Internal Revenue Code § 280E bars businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. Schedule III lifts that. For dispensaries, this is an enormous margin improvement, effective tax rates in the licensed cannabis industry have run far above normal corporate rates purely because of 280E. Licensed operators with better margins can compete harder on price, and hemp's structural price advantage narrows.

2. It strengthens the case for pulling hemp into the licensed channel. Several states are already doing this. Illinois passed a law effective November 12, 2026 routing intoxicating hemp into its cannabis framework. Ohio did it in March 2026. New York regulators told their legislature in February 2026 that intoxicating hemp should move into the adult-use system. Rescheduling gives that argument more force, not less.

3. It is already producing second-order effects. In August 2026, Georgia's medical cannabis commission proposed rules permitting delivery via USPS, FedEx and UPS, with officials attributing the change to the rescheduling action. That is a state proposal, not a federal mailability rule, USPS has not endorsed anything and no federal rule has changed, but it is the first concrete sign that rescheduling is being read as loosening the shipping question that has always constrained this industry.

What it does not do for hemp

To be blunt: rescheduling does not help hemp products at all. The two tracks are separate, and they are moving in opposite directions.

While marijuana moves toward Schedule III, hemp is moving toward tighter regulation. The federal hemp redefinition, total THC inclusive of THCA at 0.3%, plus a 0.4 mg per-container cap on finished products, is scheduled for November 12, 2026. The Senate voted on August 8 to move that to December 11 for naturally-derived products, but that is not law yet and the House has not acted.

If both land as currently written, the result is a genuine inversion: state-licensed marijuana becomes a Schedule III substance with normal tax treatment, while hemp-derived THC products that are legal today become federally controlled. The regulated market gets easier; the unregulated one closes.

One thing DEA did not do

Worth stating because rumors circulate: DEA took no scheduling action against any hemp cannabinoid between July 1 and August 18, 2026. Its scheduling activity in that window covered insomnia medications, a precursor chemical, phenethyl halides, tianeptine, and, relevant if you carry adjacent categories, 7-hydroxymitragynine and related kratom compounds, placed in Schedule I on July 6, 2026. Nothing touching hemp.

All of the current federal risk to hemp is legislative, coming from Section 781, not from DEA scheduling.

Frequently Asked Questions

Is marijuana Schedule III now?

Partly. Since April 28, 2026, marijuana in FDA-approved drug products and marijuana subject to a state medical marijuana license are Schedule III. Bulk marijuana, unlicensed crops, and unapproved derivatives and extracts remain Schedule I. The broader question is still pending.

When will the DEA decide on full rescheduling?

There is no deadline. Post-hearing briefs were filed August 17, 2026. The ALJ issues a recommended decision, parties get 20 days to file exceptions, and the DEA Administrator makes the final call without being bound by the ALJ.

Does rescheduling make hemp THC products legal?

No. They are separate legal tracks. Hemp is governed by the Farm Bill definition, which is scheduled to narrow on November 12, 2026 regardless of what happens with marijuana scheduling.

Would Schedule III let dispensaries ship cannabis to me?

Not by itself. Schedule III substances still require DEA registration and, generally, a prescription for lawful distribution, and state cannabis programs are not built on that model. A Georgia commission has proposed mail delivery for medical cannabis citing rescheduling, but no federal mailability rule has changed.

What is 280E and why does it matter?

IRC § 280E bars businesses trafficking in Schedule I or II substances from deducting normal business expenses, which has kept effective tax rates in licensed cannabis punishingly high. Schedule III removes that burden and materially improves dispensary margins.

Published August 18, 2026. General information, not legal advice. We update this page as the rescheduling process moves.